Resource Center: Treatment Algorithm
Search Results
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Logistics of buprenorphine treatment
- Addiction
- Dependence
- Discontinuation
- Dosing
- Induction
- Maintenance
- Methadone
- Pain
- Pharmacology
- Relapse
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Buprenorphine Dosing Algorithms
Flow charts are included for patients addicted to short- and long-acting opioids, for non-physically dependent patients, and for patients switching from buprenorphine to buprenorphine/naloxone.
ASAM Patient Placement Criteria
According to the Patient Placement Criteria, the following 6 patient dimensions should be considered when formulating a treatment plan (Mee-Lee et al. 2001):
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Day 1
This dosing flow chart depicts clinical dosing guidelines for patients physically dependent on short-acting opioids such as heroin.
Day 1
This dosing flow chart depicts clinical dosing guidelines for patients physically dependent on long-acting opioids such as methadone.
Day 2+
This flow chart depicts clinical guidelines for Day 2 of induction for non-physically dependent patients.
Buprenorphine Induction for Patients Physically Dependent on Short- or Long-Acting Opioids
Guidelines are provided for if the withdrawal symptoms are present since the last dose, if the withdrawal symptoms continue, if the withdrawal symptoms return, and establishing the daily dose.
Days 2+
This dosing flow chart depicts clinical guidelines for patients who are physically dependent on short- or long- acting opioids.
- Home
- Training/CME
- Resources
- How-To Guides
- All How-To Guides
- Get Started Prescribing Buprenorphine
- Assess and Treat Patients with Comorbid Health Issues
- Conduct Buprenorphine Induction
- Establish and Manage a Buprenorphine Practice
- Manage Challenging Patients
- Comply with Rules, Regulations, and Recordkeeping
- Understand Insurance and Billing Issues
- Screen for Substance Abuse
- Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
- Your Bup Site!
Current search
Resource Type
: Treatment AlgorithmRefine your results
Click a term to refine your current search.
Topics
Commonly Used Forms
Physician stage in practice
- Just became waivered (16)
- Experienced prescriber (14)
- Need to refer (2)
- Setting up a practice (2)
Resource Type
: all » Treatment AlgorithmTags
- Addiction (12)
- Adolescents (1)
- Assessment (1)
- Behavioral therapy (1)
- Comorbidities (3)
- Complicated patients (1)
- Complications (1)
- Dependence (13)
- Detoxification (2)
- Diagnosis (1)
- Discontinuation (1)
- Dosing (13)
- Drug interactions (1)
- Expert panel (1)
- Hepatitis (1)
- Heroin (5)
- HIV/AIDS (1)
- Induction (10)
- Intake (1)
- Maintenance (4)
- Methadone (5)
- Overdose (1)
- Pain (1)
- Pharmacology (3)
- Pharmacotherapy (2)
- Pharmacy (1)
- Polysubstance use (1)
- Precautions (1)
- Pregnant (1)
- Psychiatric (2)
- Psychosocial (4)
- Referral (1)
- Relapse (5)
- Risk factors (2)
- Screening (2)
- Side effects (6)
- Special populations (3)
- Suboxone (12)
- Symptoms (10)
- Tapering (2)
- Tolerance (1)
- Withdrawal (12)

